Aerska has raised $21 million in seed funding to develop RNA-interfering molecules to treat Alzheimer's and Parkinson's diseases. The Dublin-based startup emerged from stealth with 15 employees.
Amount Raised
$21 Million
Round Type
Seed
DublinBiotechnologyHealth CareMedicalTherapeuticsInvestors
Description
Aerska, a startup focused on delivering RNA-interfering molecules into the brain, has successfully secured $21 million in seed funding. The company aims to address neurodegenerative diseases like Alzheimer's and Parkinson's. Founded by seasoned RNA veterans, Aerska is innovating with a technology referred to as 'brain shuttles.' With a team of 15 based in Ireland, the UK, and the US, Aerska is poised to make significant advancements in the field.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Aerska that raised within 45 days of this round, from Fundz verified event records.
- Damora Therapeutics, Inc. raised $285M on November 12, 2025.
- Faeth Therapeutics raised $25M (Funding Round) on October 20, 2025.
- Mati Therapeutics raised $9.9M on September 30, 2025.
- MAIA Biotechnology raised $2.3M (Grant) on September 24, 2025.
- Nuclide Therapeutics raised $6.7M (Seed) on September 22, 2025.
- Immuneering raised $25M on August 26, 2025.
Who to call at Aerska, and when
A new round usually means Aerska is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aerska raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aerska, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aerska. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aerska raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Aerska raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.